Chemotherapy Drugs
ApprovedSmall molecule
Chemotherapy Drugs is one of 80 small molecule programs targeting Carcinosarcoma. It is currently in Approved.
3
Indications
5
Total Trials
3
Active Trials
79
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
1063 competitors in Pancreatic Cancer
#DrugCompanyPhaseTrials
1Chemotherapy Drugs
AARCAGY/ GINECO GROUP
Approved
Gemzar
GGynecologic Oncology Group
Preclinical
Medrol
PfizerPreclinical
Active Comparator
ModernaPreclinical
LDE225
NovartisPreclinical
Meglitinides
SanofiPreclinical
Chemotherapy Agents
TakedaPreclinical
Secretin-Ferring
FerringPreclinical
Rybelsus
PfizerPreclinical
Gemcitabine/nab-Paclitaxel
Eli LillyPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Expected Milestones
Clinical
Trials by Indication[1]
Treatment1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Chemotherapy Drugs. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Approved[1]
- Company
- AARCAGY/ GINECO GROUP